(4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid
C16H26N2O6S — CID 134836791
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid
(4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid (PubChem CID 134836791) has the molecular formula C16H26N2O6S and a molecular weight of 374.46 g/mol. Its IUPAC name is (4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid.
Molecular Properties
| Compound Name | (4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid |
|---|---|
| PubChem CID | 134836791 |
| Molecular Formula | C16H26N2O6S |
| Molecular Weight | 374.46 g/mol |
| Exact Mass | 374.15 |
| IUPAC Name | (4S)-2-[[2-carboxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methyl]-1,3-thiazolidine-4-carboxylic acid |
| SMILES | CC(C)(C)OC(=O)N1CCCCC1(CC1N[C@@H](C(=O)O)CS1)C(=O)O |
| InChI | InChI=1S/C16H26N2O6S/c1-15(2,3)24-14(23)18-7-5-4-6-16(18,13(21)22)8-11-17-10(9-25-11)12(19)20/h10-11,17H,4-9H2,1-3H3,(H,19,20)(H,21,22)/t10-,11?,16?/m1/s1 |
| InChIKey | WEOPYABFGRAUOV-VHTNMKBUSA-N |
| XLogP | 1.74 |
| TPSA | 116.17 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.46 |
| LogP ≤ 5 | 1.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134836791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.